Format
Sort by
Items per page

Send to

Choose Destination

Best matches for drd5 schizophrenia:

Search results

Items: 1 to 20 of 36

1.

Associations between a locus downstream DRD1 gene and cerebrospinal fluid dopamine metabolite concentrations in psychosis.

Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.

Neurosci Lett. 2016 Apr 21;619:126-30. doi: 10.1016/j.neulet.2016.03.005. Epub 2016 Mar 5.

2.

Relationship between genetic polymorphisms in the DRD5 gene and paranoid schizophrenia in northern Han Chinese.

Zhao Y, Ding M, Pang H, Xu XM, Wang BJ.

Genet Mol Res. 2014 Mar 12;13(1):1609-18. doi: 10.4238/2014.March.12.13.

3.

Psychosis-proneness correlates with expression levels of dopaminergic genes.

Grant P, Gabriel F, Kuepper Y, Wielpuetz C, Hennig J.

Eur Psychiatry. 2014 Jun;29(5):304-6. doi: 10.1016/j.eurpsy.2013.12.002. Epub 2014 Mar 14.

PMID:
24630741
4.

Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia.

Kordi-Tamandani DM, Sahranavard R, Torkamanzehi A.

Psychiatr Genet. 2013 Oct;23(5):183-7. doi: 10.1097/YPG.0b013e328363d6e1.

PMID:
23851595
5.

Identification of rare copy number variants in high burden schizophrenia families.

Van Den Bossche MJ, Strazisar M, Cammaerts S, Liekens AM, Vandeweyer G, Depreeuw V, Mattheijssens M, Lenaerts AS, De Zutter S, De Rijk P, Sabbe B, Del-Favero J.

Am J Med Genet B Neuropsychiatr Genet. 2013 Apr;162B(3):273-82. doi: 10.1002/ajmg.b.32146. Epub 2013 Mar 15.

PMID:
23505263
6.

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.

Hwang R, Tiwari AK, Zai CC, Felsky D, Remington E, Wallace T, Tong RP, Souza RP, Oh G, Potkin SG, Lieberman JA, Meltzer HY, Kennedy JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Apr 27;37(1):62-75. doi: 10.1016/j.pnpbp.2011.11.018. Epub 2011 Dec 8.

PMID:
22203087
7.

Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?

Urhan-Kucuk M, Erdal ME, Ozen ME, Kul S, Herken H.

Mol Biol Rep. 2011 Apr;38(4):2569-72. doi: 10.1007/s11033-010-0396-4. Epub 2010 Nov 26.

PMID:
21110120
8.

Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.

Zhan L, Kerr JR, Lafuente MJ, Maclean A, Chibalina MV, Liu B, Burke B, Bevan S, Nasir J.

Neuropathol Appl Neurobiol. 2011 Feb;37(2):206-19. doi: 10.1111/j.1365-2990.2010.01128.x.

PMID:
20874815
9.

Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.

Müller DJ, Zai CC, Sicard M, Remington E, Souza RP, Tiwari AK, Hwang R, Likhodi O, Shaikh S, Freeman N, Arenovich T, Heinz A, Meltzer HY, Lieberman JA, Kennedy JL.

Pharmacogenomics J. 2012 Apr;12(2):156-64. doi: 10.1038/tpj.2010.65. Epub 2010 Aug 17.

PMID:
20714340
10.

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia.

Zai CC, Tiwari AK, King N, De Luca V, Mueller DJ, Shaikh S, Wong GW, Meltzer HY, Lieberman JA, Kennedy JL.

Schizophr Res. 2009 Oct;114(1-3):33-8. doi: 10.1016/j.schres.2009.07.010. Epub 2009 Aug 13.

PMID:
19682861
11.

Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.

Pal P, Mihanović M, Molnar S, Xi H, Sun G, Guha S, Jeran N, Tomljenović A, Malnar A, Missoni S, Deka R, Rudan P.

Croat Med J. 2009 Aug;50(4):361-9.

12.

Association of dopamine receptor D5 gene polymorphism with peculiarities of voluntary attention in schizophrenic patients and their relatives.

Golimbet VE, Alfimova MV, Gritsenko IK, Lezheiko TV, Ebstein R.

Bull Exp Biol Med. 2008 Jan;145(1):65-7.

PMID:
19024005
13.

Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.

Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S, O'Donovan MC, Nakamura J, Ozaki N, Iwata N.

Pharmacogenomics. 2008 Oct;9(10):1437-43. doi: 10.2217/14622416.9.10.1437.

PMID:
18855532
15.

Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.

Wu WL, Burnett DA, Spring R, Greenlee WJ, Smith M, Favreau L, Fawzi A, Zhang H, Lachowicz JE.

J Med Chem. 2005 Feb 10;48(3):680-93.

PMID:
15689153
16.

No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample.

Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ.

Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):6-9.

PMID:
15635698
17.

Polymorphisms in the dopamine D5 receptor (DRD5) gene and ADHD.

Mill J, Curran S, Richards S, Taylor E, Asherson P.

Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):38-42.

PMID:
14755441
18.

Molecular genetics of schizophrenia: a critical review.

Berry N, Jobanputra V, Pal H.

J Psychiatry Neurosci. 2003 Nov;28(6):415-29. Review.

19.

Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity.

Centonze D, Grande C, Saulle E, Martin AB, Gubellini P, Pavón N, Pisani A, Bernardi G, Moratalla R, Calabresi P.

J Neurosci. 2003 Sep 17;23(24):8506-12.

20.

Supplemental Content

Loading ...
Support Center